Liu Qian-cheng, Liu Xin, Wu Min-hua, Zhou Shao-hua, Meng Li-feng. Experimental research advances of treating peritoneal dialysis-related peritoneal fibrosis with traditionalChinese medicine[J]. Journal of Clinical Nephrology, 2022, 22(7): 601-605. DOI: 10.3969/j.issn.1671-2390.2022.07.012
    Citation: Liu Qian-cheng, Liu Xin, Wu Min-hua, Zhou Shao-hua, Meng Li-feng. Experimental research advances of treating peritoneal dialysis-related peritoneal fibrosis with traditionalChinese medicine[J]. Journal of Clinical Nephrology, 2022, 22(7): 601-605. DOI: 10.3969/j.issn.1671-2390.2022.07.012

    Experimental research advances of treating peritoneal dialysis-related peritoneal fibrosis with traditionalChinese medicine

    • Peritoneal fibrosis is the most common type of peritoneal lesions in peritoneal dialysis (PD)patients. It is characterized by abnormal production of extracellular matrix protein,thickening of peritoneal interstitial connective tissue,damage of peritoneal mesothelial cells and neovascularization. Currently there is no effective therapy. Traditional Chinese medicine offers unique advantages in the prevention and treatment of peritoneal fibrosis. With an excellent clinical efficacy,it has demonstrated some promising results of experimental research. This review summarized the latest advances of animal models,single/compound herbal medications and acupuncture in the treatment of PD. It provided basic theoretical guidance for clinical application of Chinese medicine in the prevention and treatment of PD-related peritoneal fibrosis.
    • loading

    Catalog

      Turn off MathJax
      Article Contents

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return